A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder

Eduard Vieta; Stuart Montgomery; Ahmad Hatim Sulaiman; Rodrigo Córdoba; Benedicte Huberlant; Lupe Martínez; A. Schreiner

doi:10.1016/j.euroneuro.2012.03.004

Back

Shared by

Eduard Vieta

A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder

Article 2012 en

Authors

Eduard Vieta
SM
Stuart Montgomery
AS
Ahmad Hatim Sulaiman

Related publications

Article2010

P03-359 Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Long-Acting Injectable in Relapse Prevention in Patients with Bipolar I Disorder

Stuart Montgomery, Eduard Vieta, Ahmad Hatim Sulaiman, Rodrigo Córdoba, Benedicte Huberlant, A. Schreiner, G. Martinez

Article2009

A 6-month, Randomized, Placebo-controlled, Double Blind Trial of Ziprasidone Plus a Mood Stabilizer in Subjects With Bipolar I Disorder

Eduard Vieta, Charles L. Bowden, Kathleen Ice, Oksana Gurtovaya, Jeffrey H. Schwartz, P. Wang

Article2015

Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: Randomised double-blind placebo-controlled trial

Lakshmi N. Yatham, Eduard Vieta, Guy M. Goodwin, Michel Bourin, Christian de Bodinat, Judith Laredo, Joseph R. Calabrese

Article2008

A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder

Eduard Vieta, Núria Cruz, Javier García‐Campayo, Rosario de Arce, José Manuel Crespo, Vicenç Vallès, Josefina Pérez‐Blanco, Ernesto Roca, J.M. Olivares, Ángel Moríñigo, Raul Fernández-Villamor, Mercé Comes

Article2006

A Double-Blind, Randomized, Placebo-Controlled, Prophylaxis Study of Adjunctive Gabapentin for Bipolar Disorder

Eduard Vieta, José Manuel Goikolea, Anabel Martínez‐Arán, Mercé Comes, K. Verger, Xavier Masramón, José Sánchez‐Moreno, Francesc Colom

A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder

Discussion(0)

Related publications

P03-359 Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Long-Acting Injectable in Relapse Prevention in Patients with Bipolar I Disorder

A 6-month, Randomized, Placebo-controlled, Double Blind Trial of Ziprasidone Plus a Mood Stabilizer in Subjects With Bipolar I Disorder

Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: Randomised double-blind placebo-controlled trial

A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder

A Double-Blind, Randomized, Placebo-Controlled, Prophylaxis Study of Adjunctive Gabapentin for Bipolar Disorder